This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow P3Rs: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newman, T. B.
Right arrow Articles by MD, A. M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newman, T. B.
Right arrow Articles by MD, A. M. G.
Related Collections
Right arrow Nutrition & Metabolism

PEDIATRICS Vol. 105 No. 3 March 2000, pp. 637-638

COMMENTARY:
Cholesterol Screening in Children and Adolescents

The first 20% of the full text of this article appears below.

The Committee on Nutrition of the American Academy of Pediatrics recently reiterated its recommendation that children and adolescents with a family history of high blood cholesterol or premature cardiovascular disease should be screened for high blood cholesterol.1 In contrast, the American College of Physicians (ACP) does not recommend cholesterol screening in adults who may have familial hypercholesterolemia or other risk factors for coronary heart disease (CHD) until at least 25 to 30 years old in men and 35 to 40 years old in women.2 Why the discrepant recommendations, and which ones should clinicians follow?

A review of the 2 sets of recommendations and their supporting documentation reveals a difference in the quality and quantity of evidence cited to support them. The ACP guideline is based on an exhaustive review of 45 clinical trials and 8 meta-analyses of cholesterol reduction. It includes projections of costs and of numbers-needed-to-treat to prevent 1 death in different risk groups.3 In contrast, the Committee on Nutrition statement primarily cites studies of cholesterol and arteriosclerosis in animals (7 references), cross-national comparisons (15 references), and studies of familial aggregation and tracking of cholesterol levels (16 references). The Committee on Nutrition does not quantify the costs or estimate the effects of the . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
CLIN PEDIATRHome page
S. de Ferranti, D. Shapiro, R. Markowitz, E. Neufeld, N. Rifai, and H. Bernstein
Nonfasting Low-Density Lipoprotein Testing: Utility for Cholesterol Screening in Pediatric Primary Care
Clinical Pediatrics, June 1, 2007; 46(5): 441 - 445.
[Abstract] [PDF]


Home page
PediatricsHome page
L. A. Friedman, J. A. Morrison, S. R. Daniels, W. F. McCarthy, and D. L. Sprecher
Sensitivity and Specificity of Pediatric Lipid Determinations for Adult Lipid Status: Findings From the Princeton Lipid Research Clinics Prevalence Program Follow-up Study
Pediatrics, July 1, 2006; 118(1): 165 - 172.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
T. B. Newman
If It's Not Worth Doing, It's Not Worth Doing Well
Pediatrics, January 1, 2005; 115(1): 196 - 196.
[Full Text] [PDF]


Home page
PediatricsHome page
S. S. Gidding;, T. B. Newman, and A. M. Garber
Cholesterol Guidelines Debate
Pediatrics, May 1, 2001; 107(5): 1229 - 1230.
[Full Text]

P3Rs:

Read all P3Rs

Pediatric Cholesterol Screening is Adult Case Finding
David Hamburger
Pediatrics Online, 2 Mar 2000 [Full text]
Response to Dr. Hamburger
Thomas B Newman
Pediatrics Online, 8 Mar 2000 [Full text]